RUNX1 promotes pathological retinal angiogenesis through von Willebrand factor
Our present findings establish RUNX1 as a promising therapeutic target for retinal pathological angiogenesis, with its effect mediated via the vWF axis.
Authors
- Jingna He
- Xiaogang Luo
- Ailing Sui (ORCID: https://orcid.org/0000-0002-5803-9253)
- Ye Liu (ORCID: https://orcid.org/0000-0001-5827-5240)
- Yating Zhang (ORCID: https://orcid.org/0000-0002-6927-8452)
- Di Wu (ORCID: https://orcid.org/0000-0003-0889-3037)
Institutions
- University of Science and Technology of China (CN)
- Chinese University of Hong Kong (HK)
- Zhejiang Technical Institute of Economics (CN)
- Hangzhou DAC Biotech (China) (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Advances in Ophthalmology Practice and Research
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1016/j.aopr.2025.11.006
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00